美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR KBW Capital Markets ETF

158.82

+1.831.17%

盤後：158.820.00000.00%19:30 EDT

成交量：1.70萬

成交額：267.90萬

市值：5.20億

市盈率：15.00

高：158.90

開：156.83

低：156.50

收：156.99

52周最高：173.07

52周最低：132.31

股本：327.50萬

流通股本：327.50萬

量比：0.11

換手率：0.52%

股息：2.68

股息率：1.69%

每股收益(TTM):10.59

每股收益(LYR):3.09

淨資產收益率：1.92%

總資產收益率：1.11%

市淨率：1.24

市盈率(LYR):51.37

資料載入中...

總覽公司新聞資訊公告

【券商聚焦】國盛證券維持同程旅行（00780）買入評級指公司基本面韌性極強

【券商聚焦】國元證券予中廣核新能源（01811）買入評級指裝機增長強化回報

【券商聚焦】國元證券維持中糧家佳康（01610）買入評級指養殖成本降生鮮扭虧

【券商聚焦】國信證券維持石四藥集團（02005）優於大市評級指經營拐點確立

【券商聚焦】東吳證券維持華潤燃氣（01193）買入評級指業績企穩且股東回報增強

【券商聚焦】國信證券維持智譜（02513）「優於大市」評級指API收入大增

【新股IPO】麥科田（02041）首掛破發午後較招股價低超34%

佣金率下行擠壓行業盈利中證協調研探索券商差異化服務定價轉型

東方證券：景氣回升與擴表共振券商業績彈性加速釋放

券商投顧淨收入：15家翻倍式增長，2家「百億」券商下滑

南方都市报

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

博拓生物：將通過投併購等方式，在醫療大健康領域開闢新的增長賽道

順豐「躺槍」？珍視明緊急回應抽檢不合格，IPO正常推進中

【券商聚焦】中國銀河：多空角力加劇，9月債市步入季節性考驗窗口

【券商聚焦】中國銀河：美國非農數據超預期，料短期對港股估值形成壓制

【券商聚焦】中國銀河：9月A股業績催化邊際減弱，資金面尚需觀察量能信號

深圳麥科田生物醫療技術股份有限公司開盤報10港元, IPO價15.42港元。

【券商聚焦】國泰海通證券：預計全球乳清蛋白價格將維持高位

【券商聚焦】國泰海通證券：預計26Q3生豬行業繼續

【券商聚焦】國泰海通證券：五家中央險企獲特定對象注資，維持行業「增持」評級

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KCE/news?page=35"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KCE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCE\",,,,,undefined,":{"symbol":"KCE","market":"US","secType":"STK","nameCN":"SPDR KBW Capital Markets ETF","latestPrice":158.82,"timestamp":1789761600000,"preClose":156.99,"halted":0,"volume":16991,"hourTrading":{"tag":"盘后","latestPrice":158.82,"preClose":158.82,"latestTime":"19:30 EDT","volume":16,"amount":2541.12,"timestamp":1789774206364,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011656793426332785,"floatShares":3275000,"shares":3275000,"eps":10.591066,"marketStatus":"休市中","change":1.83,"latestTime":"09-18 16:00:00 EDT","open":156.83,"high":158.9,"low":156.5,"amount":2679025.8509299997,"amplitude":0.015288,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":10.591066,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.99,"sharesOutstanding":3250000,"nav":158.698515,"aum":523705099.76,"dividendRate":0.016869,"bidAskSpread":0.001426,"preHourTrading":{"tag":"盘前","latestPrice":156.99,"preClose":156.99,"latestTime":"07:37 EDT","volume":1,"amount":156.99,"timestamp":1789731425528,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":158.82,"preClose":158.82,"latestTime":"19:30 EDT","volume":16,"amount":2541.12,"timestamp":1789774206364,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.1140709171403503,"impliedVol":0.2653,"impliedVolPercentile":0.9602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCE\",,,,,undefined,":{"symbol":"KCE","floatShares":3275000,"roa":"1.11%","roe":"1.92%","lyrEps":3.09153,"volumeRatio":0.1140709171403503,"shares":3275000,"dividePrice":2.679135,"high":158.9,"amplitude":0.015288,"preClose":156.99,"low":156.5,"week52Low":132.305,"pbRate":"1.24","psRate":"51.38","week52High":173.07,"institutionHeld":16.2854,"latestPrice":158.82,"eps":10.591066,"divideRate":0.016869,"volume":16991,"delay":0,"ttmEps":10.591066,"open":156.83,"prevYearClose":149.9292,"prevWeekClose":163.28,"prevMonthClose":171.03,"prevQuarterClose":147.2354,"fiveDayClose":163.28,"twentyDayClose":166.07,"sixtyDayClose":148.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KCE\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"KCE","amount":0.551115,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-23"},{"date":"2026-06-22","symbol":"KCE","amount":0.697053,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"KCE","amount":0.717599,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"KCE","amount":0.726809,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"KCE","amount":0.537674,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR KBW Capital Markets ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KCE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.286677,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.327788,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.241445,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.260841,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.302683,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KCE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KCE\",pageSize:20,pageCount:35,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665706394","title":"【券商聚焦】國盛證券維持同程旅行（00780）買入評級 指公司基本面韌性極強","url":"https://stock-news.laohu8.com/highlight/detail?id=2665706394","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665706394?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:33","pubTimestamp":1788762789,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国盛证券发布研报指，同程旅行 2026年二季度实现收入49.87亿元，同比增长6.8%，其中核心OTA收入43.44亿元，同比增长8%。盈利能力方面，公司二季度毛利率66.7%，同比提升1.7个百分点；单季度OTA经营利润率26.4%，同比下降0.3个百分点。对应二季度经调整利润8.51亿元，同比增长10%，经调整净利润率17.1%，同比提升0.5个百分点。截至2026年中报，同程87%的注册用户来自非一线城市。研报认为公司基本面韧性极强，当前估值性价比明显，维持“买入”评级。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990918","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","002670","00780"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394178","title":"【券商聚焦】國元證券予中廣核新能源（01811）買入評級 指裝機增長強化回報","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394178","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394178?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:25","pubTimestamp":1788762328,"startTime":"0","endTime":"0","summary":"2026H1公司收入同比下降9.8%至7.73亿美元，归母净利润同比下降49.8%至0.82亿美元。补贴回款方面，2026H1公司回收补贴约4.11亿元人民币，同比增加3.83亿元；截至6月底公司计提预期信用损失后补贴净值92.5亿元，预期2026年下半年补贴资金回款有望加速。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990885","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000728","01811","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394170","title":"【券商聚焦】國元證券維持中糧家佳康（01610）買入評級 指養殖成本降生鮮扭虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394170","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394170?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:25","pubTimestamp":1788762317,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国元证券经纪 发布研报指，中粮家佳康2026年上半年实现营业收入87.36亿元，同比下滑2.5%，主要受生猪养殖、生猪鲜肉及肉类进口业务拖累。生物资产公允价值调整前，公司净利润亏损10.95亿元， 年同期为盈利2.03亿元，主要由于生猪销售价格同比大幅下降，养殖业务利润受到挤压。研报维持“买入”评级，目标价1.40港元，较现价有31.45%的涨幅空间。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01610","000728","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394532","title":"【券商聚焦】國信證券維持石四藥集團（02005）優於大市評級 指經營拐點確立","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394532","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394532?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:12","pubTimestamp":1788761548,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国信证券发布研报指，石四药集团 2026年上半年经营拐点确立，实现收入23.6亿港元，归母净利润3.2亿港元，环比2025年下半年收入增长17.0%、净利润增长71.2%，恢复性增长趋势明确。2026年以来回购1347万股库存股，大股东增持2140万股，合计耗资约1.1亿港元；截至2026年6月末账面现金约18.6亿港元。风险提示包括集采风险、原料药价格波动、药物研发及推广低于预期。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990883","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002736","KCE","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665239458","title":"【券商聚焦】東吳證券維持華潤燃氣（01193）買入評級 指業績企穩且股東回報增強","url":"https://stock-news.laohu8.com/highlight/detail?id=2665239458","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665239458?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:04","pubTimestamp":1788761063,"startTime":"0","endTime":"0","summary":"金吾财讯 | 东吴证券发布研报指，华润燃气 发布2026年中期业绩，2026H1实现营收533.81亿港元，同比+5.2%；归母净利润24.29亿港元，同比+1.0%；拟派中期股息30港仙/股，同比持平，派息率28%。业绩总体企稳，零售气量正增长。经营现金流改善，股东回报增强。上半年累计回购3,785万股、耗资约6.98亿港元，回购叠加稳定分红增厚股东回报。东吴证券维持2026至2028年公司归母净利润预测为35.78/37.30/39.60亿港元，对应PE9.3/9.0/8.4倍，分红派息稳定，维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990828","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGCF","TPFC","DIVG","MYLD","SYLD","PKW","IDVY","LCOW","LYLD","COWZ","01193","KCE","STXD","IPKW","601555","SHRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665439453","title":"【券商聚焦】國信證券維持智譜（02513）「優於大市」評級 指API收入大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2665439453","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665439453?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:00","pubTimestamp":1788760815,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国信证券发布研报指，智谱 2026年上半年实现收入9.54亿元人民币，同比增长399%，主要受开放平台及API收入大幅增长推动；毛利2.52亿元，同比增长163.7%，毛利率26.4%，同比下降23.3个百分点，因收入结构切换。该业务毛利率由上年同期-0.4%提升至24.6%，较2025年全年18.9%提升5.7个百分点。国信证券调整2026-2028年收入预测为62/155/344亿元人民币，调整幅度为+102%/81%/69%；调整归母净利润至-36/-30/5亿元，对应2026年PS约82倍，维持“优于大市”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990880","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02513","OTX.SI","KCE","002736"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399736","title":"【新股IPO】麥科田（02041）首掛破發 午後較招股價低超34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399736","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399736?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 13:13","pubTimestamp":1788757995,"startTime":"0","endTime":"0","summary":"金吾财讯 | 麦科田（02041）首日挂牌惟表现欠佳，午后维持于低位，最新报10.06港元，较招股价低34.76%，成交额9881.2万港元。今早首挂开报10.00港元，较招股价低14.77%，每股100股，不计手续费，账面亏损542元。据招股结果，股份最终发售价厘定为每股15.42港元，香港公开发售获大幅超额认购，有效申请57,305份，认购倍数约436.37倍，一手中签率为5.00%。国际发售获适度超额认购，认购倍数约2.35倍。","market":"us","thumbnail":"https://static.szfiu.com/news/20220324/OTU4MzQ2OThiZDJjMjUyYzEwMTY0ODA5MDg2MDM1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/OTU4MzQ2OThiZDJjMjUyYzEwMTY0ODA5MDg2MDM1OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990891","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","IPOS","REDS","FRHC","02041","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399388","title":"佣金率下行擠壓行業盈利 中證協調研探索券商差異化服務定價轉型","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399388","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:14","pubTimestamp":1788754484,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665965423","title":"東方證券：景氣回升與擴表共振 券商業績彈性加速釋放","url":"https://stock-news.laohu8.com/highlight/detail?id=2665965423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665965423?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:17","pubTimestamp":1788751038,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，东方证券发布研报称，负债表扩张共同推动ROE回升，其中经营杠杆升至6.06倍，成为本轮证券业ROE上行的重要增量来源。风险提示市场成交活跃度下降;权益及固定收益市场大幅波动;资本市场改革及监管政策变化;投行业务发行不及预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600958","BK0012","BK0188","BK1564","BK1147","KCE","BK0183","03958","BK0028","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665966843","title":"券商投顧淨收入：15家翻倍式增長，2家「百億」券商下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2665966843","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665966843?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:06","pubTimestamp":1788750360,"startTime":"0","endTime":"0","summary":"2026年上半年，资本市场波动加剧，投资者对专业化的投顾服务需求直接体现在券商投顾业务收入数据上。据wind统计，在A股上市的49家券商（含母公司上市）上半年投资咨询业务（简称“投顾”）净收入合计43.80亿元，同比增长59.75%，增速高于合计营收增速，但对营收贡献依旧较小，占比为1.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866485112.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866485112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LGHT","BK1583","HART","BK1100","BK4127","LNGR","IEIH","KCE","REDS","MEDX","09996","FRHC","PTH","AGNG","159883","RSPH","IPOS","MDEV","GDOC","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665339595","title":"博拓生物：將通過投併購等方式，在醫療大健康領域開闢新的增長賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2665339595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665339595?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:37","pubTimestamp":1788748667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCE","MYLD","BK4585","XMMO","CALF","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665395509","title":"順豐「躺槍」？珍視明緊急回應抽檢不合格，IPO正常推進中","url":"https://stock-news.laohu8.com/highlight/detail?id=2665395509","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665395509?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:16","pubTimestamp":1788747360,"startTime":"0","endTime":"0","summary":"《星岛》获悉，珍视明实际在今年4月10号开始已陆续接到国家药监局的抽检结果通知，此后陆续开始召回相关不合格产品，并已于5月30日完成召回，召回接受率100%。换言之，珍视明方面认为，此次产品抽检不合格的原因并非源自生产环节，而是运输过程中的非正常操作导致。珍视明相关负责人表示，目前确实有IPO计划，且在常规推进当中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/2026-09-07/doc-iniqymaf0490570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","LU0405327148.USD","IE00B12V2V27.USD","IE0003795394.USD","LU1580142542.USD","IPOS","REDS","BK0232","IE00BYQNZ168.SGD","BK0197","002352","IE00BYTNYN87.SGD","LU1781817850.SGD","FRHC","BK4127","IE0003851619.USD","BK0187","BK0196","LU0405327494.USD","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665393308","title":"【券商聚焦】中國銀河：多空角力加劇，9月債市步入季節性考驗窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393308","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665393308?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:29","pubTimestamp":1788744568,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券研究表示，维持中性稳健仓位，等待确定性窗口。基本面顺风环境仍在，外需有望延续韧性，但财政发力下专项债等发行或将加速，关注供给压力回升情况、结构性降息预期发酵以及央行灵活对冲操作。市场机构多空博弈持续下，交易盘内部操作分化、险资等配置盘承接的行为分化持续扰动短期行情，重点跟踪配置盘增量资金入场及行情向配置驱动切换的可能。此外，9月为债市传统季节性偏弱窗口，利率存在阶段性上行压力，但今年基本面、流动性及险资配置仍有支撑，行情大概率震荡分化、大幅调整仍待要素观察。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MTU3MGM5Y2M3ZDk5Mjg2ODIwNjM2NDU0OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990802","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601881","BK0276","09141","03141","BK1147","BK1564","KCE","BK0188","06881"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665933773","title":"【券商聚焦】中國銀河：美國非農數據超預期，料短期對港股估值形成壓制","url":"https://stock-news.laohu8.com/highlight/detail?id=2665933773","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665933773?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:27","pubTimestamp":1788744431,"startTime":"0","endTime":"0","summary":"可以重点关注三大信号：一是南向资金能否重新形成持续净流入态势；二是恒生科技指数能否放量突破前期高点；三是AI行情能否从前期领涨的算力、PCB等硬件板块，向互联网、AI应用、Agent及Physical AI方向扩散。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990800","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK0188","BK0276","06881","VXUS","VXZ","KCAI","BK4585","ULE","BK1147","601881","KCE","BK1564","FMAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665933753","title":"【券商聚焦】中國銀河：9月A股業績催化邊際減弱，資金面尚需觀察量能信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2665933753","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665933753?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:21","pubTimestamp":1788744060,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券发布A股策略，该机构指，当前A股市场处于9月业绩空窗期，外围扰动、国内政策落地与市场量能变化成为影响后续行情的三条主要线索。综合来看，9月业绩催化边际减弱，资金面尚需观察量能信号，市场对外围风险、产业事件和政策边际变化的敏感度可能进一步提高，建议在波动中寻找政策确定性和景气兑现度更高的结构机会。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990799","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07233","02827","KCE","06881","83188","03130","601881","BK0188","BK1147","BK1564","159982","83130","02846","03188","BK0276","82846","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398078","title":"深圳麥科田生物醫療技術股份有限公司開盤報10港元, IPO價15.42港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:20","pubTimestamp":1788744046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["REDS","IPOS","FRHC","KCE","BK4127","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665639339","title":"【券商聚焦】國泰海通證券：預計全球乳清蛋白價格將維持高位","url":"https://stock-news.laohu8.com/highlight/detail?id=2665639339","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665639339?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:17","pubTimestamp":1788743835,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究指，近年来，乳清蛋白价格不断上涨，全球浓缩乳清蛋白价格在过去两年累计上涨108%，分离乳清蛋白价格涨幅高达139%，全球乳清蛋白不足，价格预计将维持高位。中国海关总署数据显示，乳清蛋白进口均价自2024年以来持续上涨，涨价已逐步传导至国内市场。在此背景下，替代蛋白关注度和需求持续提升，其中微生物蛋白生产效率高，商业化逐步落地。建议关注微生物蛋白产能布局以及应用领先的公司。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990798","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910500.SGD","LU0128522157.USD","LU1224709979.USD","BK1147","01117","LU0163747925.USD","LU1769817096.USD","161027","LU0228659784.USD","LU1048588211.SGD","LU0259732245.USD","IE00B29SXG58.USD","SG9999002828.SGD","BK1237","LU1102505929.USD","LU0640798160.USD","02319","06186","IE00B067MR52.USD","LU0029875118.USD","02611","IE0009570106.USD","SG9999014674.SGD","IE0031814852.USD","601211","LU0287142896.SGD","HK0000306701.USD","LU0173614495.USD","BK1589","LU0205439572.USD","LU0737861699.HKD","LU0594300419.USD","BK1212","09858","HK0000320223.HKD","LU0048580855.USD","LU0359201885.HKD","LU1051768304.USD","BK0012","LU0385154629.USD","BK0276","HK0000320264.USD","LU0370786039.SGD","IE00B97KM107.HKD","LU0072462343.USD","LU0348788117.USD","KCE","LU1769817179.HKD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665393322","title":"【券商聚焦】國泰海通證券：預計26Q3生豬行業繼續","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393322","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665393322?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:17","pubTimestamp":1788743831,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究指，2026年8-9月，生猪价格虽有上涨但行业仍旧亏损，同时仔猪进入淡季价格低迷，育肥猪和种猪继续亏损，26Q3该机构预计行业继续亏损利润，大部分公司亏损现金流。淘汰母猪价格在8-9月将会继续走低，淘汰母猪/育肥猪折扣降到5-6折，因此该机构认为行业亏损，尤其是政策推动，生猪养殖行业产能在当前加速淘汰。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1549","SG9999001069.SGD","SG9999002950.SGD","BK1603","02714","601211","KCE","BK0201","BK1543","LU0173614495.USD","LU0274383008.USD","SG9999001051.SGD","LU0702159699.USD","BK0276","SGXZ90724238.SGD","BK0028","LU1166156734.SGD","161027","BK0012","LU0541501648.USD","00288","BK1564","BK0184","01610","02611","BK1147","01340","LU0287142896.SGD","BK0183","LU0541502299.USD","BK1237","SG9999001226.SGD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665933033","title":"【券商聚焦】國泰海通證券：五家中央險企獲特定對象注資， 維持行業「增持」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2665933033","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665933033?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:17","pubTimestamp":1788743827,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究指，9月6日，中国人寿集团、中国人保集团、中国太平集团、中国出口信用保险公司、中国再保险集团获得特定对象注资分别350亿元、150亿元、70亿元、100亿元及30亿元，合计700亿元。该机构认为，注资对公司的股本摊薄影响有限，注资帮助中央险企提升偿付能力，利于长期稳健经营。利率异常低位背景下，保险公司资负匹配重要性抬升，围绕偿付能力以中长期利率中枢为基础的资负经营重要性抬升；当前隐含的利率预期过度悲观。维持“增持”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990796","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","KCE","02611"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":36,"pageCount":35,"totalSize":713,"code":"91000000","status":"200"}]}}